Genentech Retavase Lawsuits Are Dropped As Part Of Roche Buyout
Executive Summary
Genentech will drop its patent infringement lawsuits challenging Centocor's Retavase to become a closer affiliate of Roche, the June 14 Genentech re-issue prospectus indicates.